ImmunityBio
IBRX
IBRX
58 hedge funds and large institutions have $113M invested in ImmunityBio in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 14 closing their positions.
Holders
58
Holders Change
-2
Holders Change %
-3.33%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
24
Reduced
14
Closed
14
Calls
$1.49M
Puts
$2.04M
Net Calls
-$549K
Net Calls Change
-$549K
Top Buyers
1 |
1
BlackRock
New York
|
$20.9M |
2 |
2
Northern Trust
Chicago,
Illinois
|
$2.31M |
3 |
3
State Street
Boston,
Massachusetts
|
$2.59M |
4 |
AA
4
ALPS Advisors
Denver,
Colorado
|
$563K |
5 |
5
Charles Schwab
San Francisco,
California
|
$799K |